HopeStage
Back to all studies
CompletedNCT05906121

Blood levels during combined lidocaine and ketamine infusions

About this titleRead the official source — NCT05906121
Observational studyAges 18+SwitzerlandDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 16, 2023
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
University Hospital, Basel, Switzerland
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Drug
Locations
Switzerland
Age range
Over 18 Years
Official registry ID
NCT05906121
Official title
Show the full official title

Lidocaine and Ketamine Levels in Plasma After Simultaneous Lidocaine/Ketamine Infusions. An Observational Assessment of Therapy Effects and Side-effects.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Basel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital, Basel, Switzerland, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including lidocaine-ketamine infusions.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies